MedDataX Logo

Interactive Voice Response (IVR) for Methadone Patients

NCT ID: NCT00237406

Last Updated: 2010-03-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-01-31

Study Completion Date

2006-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to test whether a telephone call-in program is a feasible way to collect mood and drug-related information in individuals enrolled in a methadone maintenance program.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment

NCT06454903

Opioid-Related Disorders Psychosocial Functioning Quality of Life
RECRUITING NA

Harnessing Placebo Effects in Methadone Treatment

NCT02941809

Opioid-use Disorder Opioid-Related Disorders
COMPLETED NA

Attitudes Towards Buprenorphine and Methadone

NCT00911846

Addictive Opioids
UNKNOWN

Evaluating a Novel Medication Device for Methadone Dosing

NCT03254043

Opioid-use Disorder
COMPLETED NA

Demonstration of a Digital Care Program for Methamphetamine Use Disorder

NCT05206175

Methamphetamine Abuse
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will complete a baseline interview and a follow-up interview at 5-weeks post-baseline. Two-thirds of the participants will be randomized into the telephone call-in group, and will be asked to complete daily, 10-minute, telephone interviews. To complete these interviews, participants will call into a toll-free telephone interview system with a unique and private Study ID number, and answers questions by using the telephone key pad. Questions during both the face-to-face interviews and the telephone interviews will assess mood, sleep, treatment utilization and drug-related experiences. Participants will be compensated for their time.

Comparison(s): Participants randomized into the telephone component of the study as compared to participants in the interview-only component of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid-Related Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

interactive voice response

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Recent enrollment in a methadone maintenance program

Exclusion Criteria

* Enrollment in a methadone maintenance program within the prior 3 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Butler Hospital

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael D Stein, MD

Role: PRINCIPAL_INVESTIGATOR

Rhode Island Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rhode Island Hospital

Providence, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4065-05

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
NCT05976646 COMPLETED PHASE1/PHASE2
Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1
NCT00061087 COMPLETED PHASE2/PHASE3
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
NCT00000243 TERMINATED NA
Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment
NCT01442493 COMPLETED NA
Evaluating Three Methods for Helping Syringe Exchangers Begin Methadone Maintenance
NCT01142986 COMPLETED NA
A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment
NCT05189223 RECRUITING NA
Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, Indonesia
NCT01360463 COMPLETED PHASE2
Study of Computer-Based Treatment for Drug Dependence
NCT01315184 COMPLETED PHASE2
Mobile Psychosocial Interventions for MMT Clients
NCT01632982 UNKNOWN NA
Contingency Management for Stimulant Use Disorders
NCT05097547 UNKNOWN NA
Attention Training for Opioid-maintained Cocaine Users
NCT01870882 COMPLETED PHASE4
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
NCT06033599 RECRUITING PHASE3
Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.
NCT03212794 COMPLETED NA
Pilot of Mindfulness Oriented Recovery Enhancement in MethadoneTreatment
NCT03894501 COMPLETED NA
Bupropion in the Treatment of Methamphetamine Dependence
NCT00572234 COMPLETED NA
Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2
NCT00249535 COMPLETED NA
Facilitating the Implementation of Interim Methadone to Increase Treatment Access
NCT04188977 COMPLETED NA
Comparison of Buprenorphine and Methadone - 3
NCT00000334 COMPLETED PHASE2
Peer-Delivered Behavioral Activation for Methadone Adherence - Pilot Phase
NCT04248933 COMPLETED NA
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
NCT00000240 COMPLETED PHASE2
Medication-Assisted Treatment for Youth With Substance Use Disorders
NCT02593474 COMPLETED PHASE1
Brief Introductory Therapy for Opioid Dependence
NCT00406484 COMPLETED PHASE2
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
NCT05034276 COMPLETED NA
Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution
NCT01560221 COMPLETED PHASE1
Entry Into Comprehensive Methadone Treatment Via Interim Maintenance
NCT00712036 COMPLETED NA